PROFOUND MEDICAL CORP. Increase (Decrease) in Deferred Income Taxes
PROFOUND MEDICAL CORP. (PROF) reported Increase (Decrease) in Deferred Income Taxes of $18.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-08-06
- 2026-06-30: Increase (Decrease) in Deferred Income Taxes 6 month $18.00K.
- 2025-06-30: Increase (Decrease) in Deferred Income Taxes 6 month $14.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 6 month |
|---|---|
| 2026-06-30 | $18.00K 10-Q · filed 2026-08-06 |
| 2025-06-30 | $14.00K 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |